otis annual research meeting june 2010 asthma and asthma medications in pregnancy study a vaccines...

9
OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS) Project

Upload: erik-ball

Post on 02-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

OTIS ANNUAL RESEARCH MEETING JUNE 2010

Asthma and Asthma Medications in Pregnancy

Study

A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS) Project

Page 2: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

VAMPSS Project

Vaccines and Medications in Pregnancy Surveillance System

“VAMPSS” A Collaboration of:

American Academy of Allergy Asthma and Immunology Organization of Teratology Information Specialist (OTIS)

Slone Epidemiology Center at Boston University (SEC)

Page 3: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

VAMPSS Project

VAMPSS is a new nationwide post-marketing surveillance system established to comprehensively monitor the use and safety of vaccines and medications during pregnancy

The VAMPSS system provides a coordinated effort involving:

1. prospective registry surveillance coordinated by OTIS

2. case-control surveillance coordinated by SEC

Page 4: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

Asthma and Asthma Medications in Pregnancy Study-A VAMPSS Project

Study began in November 2009Prospective, observational cohort studyCoordinating center is at the University of California,

San Diego

Page 5: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

Purpose

The Asthma and Asthma Medications in Pregnancy study is researching the effects of short-acting and long-acting beta agonists used for the treatment of asthma in pregnancy

Page 6: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

Study Participation

Self-enrollment4-5 phone interviews (intake, 20wk, 32wk,

outcome, and 6 month post-partum)Medical records pertaining to the pregnancy

and outcome of the pregnancy

Page 7: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

Total Enrollment to Date

Total as of June 7, 2010

Short-acting Beta-agonists

9

Long-acting Beta-agonists

13

Controls 13

Total Enrolled 35

Page 8: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

Who Should be Referred?

Groups Criteria

Short-Acting Beta Agonist

• Diagnosed with asthma • Exposure to a short-acting beta agonist • Less than 20 weeks gestation

Long-Acting Beta Agonist

• Diagnosed with asthma• Exposure to a long-acting beta agonist (Formoterol or Salmeterol)• Less than 20 weeks gestation

Non-Disease Controls

• Pregnant women who are less than 20 weeks gestation

Page 9: OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)

How to Refer?

Toll-free number at 877-311-8972 to refer patient OR provide the patient our toll-free number

Contact via email at [email protected] a referral sheet to OTIS which is found on

our website at www.otispregnancy.org